Intellectual Property
We have an aggressive IP strategy that includes a patent on non-invasive, comprehensive, hormone testing and provisional filings on our technology and genetic integrations, as well as trademarks as applicable.
The Covid-19 “infodemic”, a term coined by the World Health Organization (WHO) to describe the dangerous nature of misinformation in the face of a health crisis, underscores the utility of applying our technology assets to any specialty area of healthcare. Access to correct, unbiased, personalized health care information can be the difference between suffering and healing, affordable treatment or snake oil, and even can mean the difference between life and death. MedAnswers is seeking partners to rapidly expand into other health are verticals, a few of which are described below.
Female led and majority owned, fully remote team with 6 exits & 6 aquisitions.
We have an aggressive IP strategy that includes a patent on non-invasive, comprehensive, hormone testing and provisional filings on our technology and genetic integrations, as well as trademarks as applicable.
Our first vertical, FertilityAnswers, was started by fertility patients, advocates, researchers and physicians who serve the market. We've worked alongside advocacy organizations and non-profits to increase access to care, better serve patients and democratize pricing. Volunteerism is a core part of every disease state in which humans are suffering. We strongly encourage our employees and partners to lend their voice to worthy causes, to make a difference in their daily actions and open their hearts to giving back.